Show simple item record

Discontinuation of somatostatin analogs while acromegaly is in long-term remission

dc.contributor.authorHatipoglu, Esra
dc.contributor.authorKadioglu, Pınar
dc.contributor.authorBozcan, Selma
dc.date.accessioned2021-03-05T15:14:38Z
dc.date.available2021-03-05T15:14:38Z
dc.date.issued2015
dc.identifier.citationHatipoglu E., Bozcan S., Kadioglu P., "Discontinuation of somatostatin analogs while acromegaly is in long-term remission", PITUITARY, cilt.18, ss.554-560, 2015
dc.identifier.issn1386-341X
dc.identifier.otherav_baf8c44d-a164-442c-89c3-9960f86231d6
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/124340
dc.identifier.urihttps://doi.org/10.1007/s11102-014-0608-3
dc.description.abstractWe aimed to evaluate the disease activity of medically controlled patients with acromegaly after withdrawal of somatostatin receptor ligands (SRL).
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleDiscontinuation of somatostatin analogs while acromegaly is in long-term remission
dc.typeMakale
dc.relation.journalPITUITARY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue4
dc.identifier.startpage554
dc.identifier.endpage560
dc.contributor.firstauthorID50221


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record